Viewing Study NCT01332461


Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2026-04-11 @ 11:31 AM
Study NCT ID: NCT01332461
Status: COMPLETED
Last Update Posted: 2017-06-27
First Post: 2011-03-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 112609
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators